Biology and pathobiology of apoE in aging and Alzheimer's disease
apoE 在衰老和阿尔茨海默病中的生物学和病理学
基本信息
- 批准号:10667435
- 负责人:
- 金额:$ 652.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAgeAge-associated memory impairmentAgingAllelesAlzheimer&aposs DiseaseAlzheimer&aposs disease diagnosisAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAlzheimer&aposs disease riskAlzheimer&aposs disease therapyAmyloid beta-ProteinAnimalsApolipoprotein EAstrocytesAutomobile DrivingAutopsyBiochemicalBiochemistryBioinformaticsBiological MarkersBiological ModelsBiologyBiometryBiophysicsBlood VesselsBrainCell NucleusCellsCollaborationsCollectionCommunitiesDataData SetDevelopmentDiseaseDisease PathwayEnsureEventFosteringGenesGeneticGenomicsGenotypeGoalsHumanImpaired cognitionInstitutionInterruptionKnowledgeLinkLipid BindingLipidsLipoproteinsLiquid substanceMediatingMicrodialysisMicrogliaModelingMolecularMultiomic DataMusNeurosciencesOrganoidsOutcomePathogenicityPathologicPathologyPathway interactionsPhysiologicalPost-Translational Protein ProcessingPrevention strategyPropertyProtein IsoformsProteinsProteomicsReagentRecommendationResearchResearch PersonnelResource SharingResourcesRiskRisk FactorsStructureSystemTestingTherapeuticTimeUnited States National Institutes of HealthVascular Cognitive ImpairmentWorkage relatedaging brainbiomarker discoverybiophysical propertiesbrain cellcell typedata managementdesignfunctional outcomesgenetic analysisgenetic risk factorhealthy agingimprovedin vivoinduced pluripotent stem cellinnovationinsightlarge datasetslipid metabolismlipidomicsmetabolomicsmouse modelmultidisciplinarymultiple omicsneuropathologyparticlepreventprotective allelerisk variantsingle-cell RNA sequencingstructural biologysymposiumsynergismtargeted treatmenttau Proteinstherapeutic developmenttreatment strategyweb portal
项目摘要
PROJECT SUMMARY (APOE U19: OVERALL)
The overarching goal of this U19 project is to comprehensively understand the biology and pathobiology of
apolipoprotein E (apoE) in aging and Alzheimer’s disease (AD) to inform therapeutic strategies. The ε4 allele of
the APOE gene (APOE4) is the strongest genetic risk factor for AD impacting 50-70% of all AD patients, while
the ε2 allele is protective compared to the common ε3 allele. APOE4 is also a strong risk factor for age-related
cognitive decline and vascular cognitive impairment. To integrate existing knowledge and address critical gaps,
we propose a unified ApoE Cascade Hypothesis that the structural differences and related biochemical
properties among the three apoE isoforms initiate their differential effects on a cascade of events at the cellular
and systems levels ultimately impacting aging-related pathogenic conditions including AD. Towards this, we
have assembled a multi-disciplinary team to synergize expertise and resources across multiple institutions. By
integrating five interactive Projects and seven robust Cores, we will create a nexus for apoE-related aging
research, sharing the knowledge, expertise and resources with the broader scientific community. Project 1 will
work closely with Core B to address the structural and biochemical properties of the three apoE isoforms to
generate insights for functional outcomes. Projects 2, 3 and 4 will interactively study how apoE isoforms
expressed in astrocytes, microglia, or vascular mural cells impact lipid metabolism, glial and vascular functions,
AD-related pathologies, and cellular and molecular pathways using conditional mouse models and systems-
based approaches. These studies will generate cell type-specific apoE/lipoprotein particles that will be
collected through in vivo microdialysis for structural and biochemical studies. Project 5 will carry out genomic
and genetic analyses to identify modifiers of APOE-related age at onset of AD. Studies in Projects 2-5 will be
interactively supplemented by neuropathological studies using postmortem brains from healthy aging studies
or with AD pathologies (Core C), biomarker studies using both human and mouse biospecimens (Core D), and
functional studies using human iPSC-derived cellular and organoid models (Core E). This U19 proposal is
supported by a comprehensive Multi-Omics Core (Core F) for centralized proteomics, lipidomics, and
metabolomics studies on various animal and iPSC models, as well as human postmortem brains and fluid
biospecimens. The Bioinformatics, Biostatistics, and Data Management Core (Core G) will provide critical
supports for analyzing large datasets including those from single-cell RNA-seq and biostatistics supports to
ensure scientific rigor. Core G will also work closely with the Administrative Core (Core A) to maintain an ApoE
Web Portal designated as EPAAD where knowledge, resources, and data will be shared with the scientific
community. Core A will also organize annual ApoE Symposium to promote collaboration and engage the ApoE
Community. As such, this U19 will drive a team-based effort to generate essential knowledge to guide disease-
modifying therapies for AD and other aging-related conditions.
项目概要(载脂蛋白E U19:总体)
这个U19项目的首要目标是全面了解的生物学和病理生物学,
载脂蛋白E(apoE)在衰老和阿尔茨海默病(AD)中的作用,为治疗策略提供信息。ε4等位基因
APOE基因(APOE 4)是AD最强的遗传风险因素,影响50-70%的AD患者,
与常见的ε3等位基因相比,ε2等位基因具有保护性。APOE 4也是年龄相关性高脂血症的一个强风险因素。
认知能力下降和血管性认知障碍。为了整合现有知识并弥补关键差距,
我们提出了一个统一的ApoE级联假说,即结构差异和相关的生化
三种apoE亚型之间的特性启动了它们对细胞内级联事件的差异效应,
和系统水平,最终影响衰老相关的致病性疾病,包括AD。为此,我们
组建了一个多学科团队,以协同多个机构的专业知识和资源。通过
整合五个互动项目和七个强大的核心,我们将为apoE相关衰老建立一个联系
研究,与更广泛的科学界分享知识,专业知识和资源。项目1将
与核心B密切合作,研究三种apoE亚型的结构和生化特性,
为功能性成果提供见解。项目2、3和4将交互式研究apoE亚型
在星形胶质细胞、小胶质细胞或血管壁细胞中表达影响脂质代谢、神经胶质和血管功能,
AD相关的病理学,以及使用条件性小鼠模型和系统的细胞和分子途径-
基于方法。这些研究将产生细胞类型特异性apoE/脂蛋白颗粒,
通过体内微透析收集用于结构和生化研究。项目5将进行基因组
和遗传分析,以确定AD发病时APOE相关年龄的修饰剂。项目2-5的研究将
交互式补充神经病理学研究,使用健康老龄化研究的死后大脑
或AD病理学(核心C),使用人和小鼠生物标本的生物标志物研究(核心D),以及
使用人iPSC衍生的细胞和类器官模型的功能研究(核心E)。U19提案是
由全面的多组学核心(核心F)支持,用于集中的蛋白质组学,脂质组学,
对各种动物和iPSC模型以及人类死后大脑和体液的代谢组学研究
生物标本生物信息学、生物统计学和数据管理核心(核心G)将提供关键的
支持分析大型数据集,包括来自单细胞RNA-seq和生物统计学的数据集,
确保科学严谨。核心G还将与行政核心(核心A)密切合作,
指定为EPAAD的门户网站,将与科学家共享知识,资源和数据。
社区核心A还将组织年度ApoE研讨会,以促进合作并吸引ApoE
社区因此,U19将推动以团队为基础的努力,以产生指导疾病的基本知识-
改变AD和其他衰老相关疾病的治疗方法。
项目成果
期刊论文数量(36)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
LRP1 in vascular mural cells modulates cerebrovascular integrity and function in the presence of APOE4.
- DOI:10.1172/jci.insight.163822
- 发表时间:2023-04-10
- 期刊:
- 影响因子:8
- 作者:Oue, Hiroshi;Yamazaki, Yu;Qiao, Wenhui;Yuanxin, Chen;Ren, Yingxue;Kurti, Aishe;Shue, Francis;Parsons, Tammee M.;Perkerson, Ralph B.;Kawatani, Keiji;Wang, Ni;Starling, Skylar C.;Roy, Bhaskar;Mosneag, Ioana-Emilia;Aikawa, Tomonori;Holm, Marie-Louise;Liu, Chia-Chen;Inoue, Yasuteru;Sullivan, Patrick M.;Asmann, Yan W.;Kim, Betty Y. S.;Bu, Guojun;Kanekiyo, Takahisa
- 通讯作者:Kanekiyo, Takahisa
Microglial TREM2 in amyotrophic lateral sclerosis.
- DOI:10.1002/dneu.22864
- 发表时间:2022-01
- 期刊:
- 影响因子:3
- 作者:Xie M;Zhao S;Bosco DB;Nguyen A;Wu LJ
- 通讯作者:Wu LJ
APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer's disease with Lewy body pathology.
- DOI:10.1007/s00401-022-02421-8
- 发表时间:2022-06
- 期刊:
- 影响因子:12.7
- 作者:
- 通讯作者:
TDP-43 Pathology in Alzheimer's Disease.
- DOI:10.1186/s13024-021-00503-x
- 发表时间:2021-12-20
- 期刊:
- 影响因子:15.1
- 作者:Meneses A;Koga S;O'Leary J;Dickson DW;Bu G;Zhao N
- 通讯作者:Zhao N
Standardized immunoprecipitation protocol for efficient isolation of native apolipoprotein E particles utilizing HJ15.4 monoclonal antibody.
- DOI:10.1016/j.xpro.2023.102271
- 发表时间:2023-06-07
- 期刊:
- 影响因子:0
- 作者:O'Leary, Justin;Raulin, Ana-Caroline;Li, Zonghua;Martens, Yuka;Inoue, Yasuteru;Strickland, Michael R.;Han, Xianlin;Holtzman, David M.;Bu, Guojun;Zhao, Na
- 通讯作者:Zhao, Na
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALISON M GOATE其他文献
ALISON M GOATE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALISON M GOATE', 18)}}的其他基金
Neuroprotective signaling and transcriptional pathways in microglia associated with Alzheimer's disease
与阿尔茨海默病相关的小胶质细胞的神经保护信号传导和转录途径
- 批准号:
10552538 - 财政年份:2022
- 资助金额:
$ 652.39万 - 项目类别:
2022 Neurobiology of Brain Disorders GRC and GRS
2022年脑部疾病神经生物学GRC和GRS
- 批准号:
10468475 - 财政年份:2022
- 资助金额:
$ 652.39万 - 项目类别:
Neuroprotective signaling and transcriptional pathways in microglia associated with Alzheimer's disease
与阿尔茨海默病相关的小胶质细胞的神经保护信号传导和转录途径
- 批准号:
10301271 - 财政年份:2022
- 资助金额:
$ 652.39万 - 项目类别:
Genetic modifiers of APOE-related risk for AD
APOE 相关 AD 风险的基因修饰
- 批准号:
10667481 - 财政年份:2021
- 资助金额:
$ 652.39万 - 项目类别:
Project 1: Determination of molecular differences caused by tauopathy-associated H1 and H2 haplotypes
项目 1:确定 tau 蛋白病相关 H1 和 H2 单倍型引起的分子差异
- 批准号:
10295517 - 财政年份:2021
- 资助金额:
$ 652.39万 - 项目类别:
Biology and pathobiology of apoE in aging and Alzheimer's disease
apoE 在衰老和阿尔茨海默病中的生物学和病理学
- 批准号:
10407934 - 财政年份:2021
- 资助金额:
$ 652.39万 - 项目类别:
Genetic modifiers of APOE-related risk for AD
APOE 相关 AD 风险的基因修饰
- 批准号:
10407948 - 财政年份:2021
- 资助金额:
$ 652.39万 - 项目类别:
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease
开发 PU.1 抑制调节剂作为阿尔茨海默病的新疗法
- 批准号:
10435506 - 财政年份:2020
- 资助金额:
$ 652.39万 - 项目类别:
Development of PU.1 Inhibitory Modulators as Novel Therapeutics for Alzheimer's Disease
开发 PU.1 抑制调节剂作为阿尔茨海默病的新疗法
- 批准号:
10159826 - 财政年份:2020
- 资助金额:
$ 652.39万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 652.39万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 652.39万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 652.39万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 652.39万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 652.39万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 652.39万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 652.39万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 652.39万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 652.39万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 652.39万 - 项目类别:
Research Grant